70
M. Svobodová et al. / Journal of Organometallic Chemistry 694 (2009) 63–71
Table 3
6.96–7.08 (m, 6.18H, maj. + min.), 7.17–7.20 (m, 2.3H, maj. + min.),
7.29–7.33 (m, 3H, maj.), 7.36–7.39 (m, 4H, maj.), 7.64–7.67 (m,
2.72H, maj. + min.), 11.84 (br q, 1H, 3J = 5.1 Hz, maj.), 13.36 (br s,
1H, maj.), 13.63 (s, 0.26 H, min.), 14.08 (s, 0.26 H, min.); 13C NMR
(125 MHz, CDCl3) major form d 20.8, 31.9, 114.2, 120.1, 120.2,
120.6, 123.3, 127.5, 128.1, 128.6, 129.1, 133.2, 136.5, 138.6,
150.0, 164.3, 172.8; minor form d 20.4, 39.7, 115.7, 120.5, 123.9,
125.8, 127.3, 127.5, 128.4, 128.7, 129.4, 132.4, 135.9, 137.8,
140.3, 163.7, 171.2. Anal. Calc. for C23H22N4O: C, 74.57; H, 5.99;
N, 15.12. Found: C, 74.40; H, 6.20; N, 15.20%.
3-Methylamino-2-(4-methylphenyldiazenyl)-N-phenylbut-2-ena-
mide (5d). The title compound was obtained (1.2 g, 39%) as yellow
crystals: recrystallization from cyclohexane, m.p. 154–155.5 °C;
1H NMR (500 MHz, CDCl3) major form d 2.30 (s, 3H), 2.34 (s,
3H), 2.88 (d, 3H, 3J = 5.2 Hz), 6.99–7.04 (m, 1.38H (maj. + min.)),
7.10–7.12 (m, 2H), 7.26–7.30 (m, 2.32H (maj. + min.)), 7.41–7.43
(m, 2H), 7.59–7.61 (m, 2H), 12.00 (q, 1H, 3J = 5.2 Hz), 13.59 (s, 1
H); minor form d 2.07 (s, 0.37H), 2.24 (s, 0.41H), 3.16 (s, 0.42H),
6.99–7.04 (m, 1.38H (maj. + min.)), 7.07–7.09 (m, 0.26H), 7.26–
7.30 (m, 2.32H (maj. + min.)), 7.54–7.55 (m, 0.35H), 13.86 (s,
1H), 14.14 (s, 1 H); 13C NMR (125.77 MHz, CDCl3) major form d
14.0, 20.9, 30.5, 119.5, 120.1, 122.8, 123.2, 128.6, 129.4, 136.4,
138.8, 150.3, 164.0, 172.2; minor form d 13.6, 20.6, 37.9, 120.5,
123.8, 128.7, 129.8, 132.4, 139.0, 140.6, 163.9, 169.6. Anal. Calc.
for C18H20N4O: C, 70.11; H, 6.54; N, 18.17. Found: C, 70.36; H,
6.44; N, 18.13%.
Reaction times, products and yields of the rearrangement of oxazaborines 2a–d in
DMF at reflux.
Reaction Products of
time
(min)
The ratio of Yield after
Yield after
the
rearrangement in the
the product chromatography crystallization
(%)
(%)
reaction
mixturea
2a 140
2a
3a
4a
2b
3b
4b
2c
3c
4c
2d
3d
4d
3
2
10
2
0.1
10
10
10
7
10
15
8
17
10
54
10
–
64
28
31
14
25
39
18
10
5
35
7
2b 140
2c 370
2d 400
–
47
20
17
7
20
28
14
a
From integration of 1H NMR.
2-(4-Methylphenyl)-3,3,5-triphenyl-4H-1,2,4,3k4-triazaborine-6-
carboxanilide (4a). Recrystallization from cyclohexane-toluene, yel-
low crystals (0.21 g, 4%): m.p. 201–204 °C; 1H NMR (500 MHz,
CDCl3) d 2.29 (s, 3H), 7.01–7.05 (m, 3H), 7.12 (br s, 1H), 7.19–
7.28 (m, 8H), 7.30–7.32 (m, 2H), 7.35–7.37 (m, 4H), 7.42–7.45
(m, 2H), 7.50–7.55 (m, 5H), 8.98 (s, 1H); 13C NMR (125 MHz, CDCl3)
d 20.9, 119.4, 123.4, 123.5, 126.7, 127.4, 128.1, 128.3, 128.4, 128.7,
128.8, 131.4, 133.4, 134.5, 137.1, 137.9, 144.8, 146.1, 157.3, 160.3.
Anal. Calc. for C34H29BN4O: C, 78.47; H, 5.62; N, 10.77. Found: C,
78.47; H, 5.87; N, 10.57%.
5-(4-Methylphenyldiazenyl)-2,2,4-triphenyl-6-[2H5]phenylamino-
3H-1,3,2k4-oxazaborine (2a). The title compound was prepared
according to the procedure B. 3-Amino-N-[2H5]phenyl-3-phenyl-
prop-2-enamide was used instead of enamide 1a. It was obtained
as yellow crystals (1.32 g, 63%): recrystallization from cyclohex-
ane-toluene, m.p. 200.5–202.5 °C; 1H NMR (500 MHz, CDCl3) d
2.24 (s, 3H), 6.93 (s, 1H), 7.04–7.06 (m, 2H), 7.16–7.20 (m, 2H),
7.23–7.28 (m, 6H), 7.37–7.40 (m, 2H), 7.42–7.45 (m, 1H), 7.50–
7.52 (m, 4H), 7.57–7.58 (m, 2H), 14.67 (s, 1H); 13C NMR
(125 MHz, CDCl3) d 21.0, 121.6 (t, 1J(13C, 2H) = 25 Hz), 125.2 (t,
1J(13C, 2H) = 25 Hz), 126.3, 127.3, 127.9, 128.7 (t, 1J(13C,
2H) = 25 Hz),129.4, 129.5, 131.0, 131.7, 135.6, 136.3, 137.7, 148.9,
149.2, 159.5, 169.3. Anal. Calc. for C34H24D5BN4O: C, 77.72; H,
6.52; N, 10.66. Found: C, 77.95; H, 6.81; N, 10.57%.
5-Methyl-2-(4-methylphenyl)-3,3-diphenyl-4H-1,2,4,3k4-triazab-
orine-6-carboxanilide (4b). Recrystallization from toluene, orange
crystals (0.17 g, 4%): m.p. 215–218.5 °C; 1H NMR (500 MHz, CDCl3)
d 2.20 (s, 3H), 2.49 (s, 3H), 6.91–6.93 (m, 2H), 7.01–7.04 (m, 1H),
7.13–7.21 (m, 8H), 7.24–7.27 (m, 2H), 7.31–7.33 (m, 4H), 7.38 (br
s, 1H), 7.50–7.52 (m, 2H), 8.91 (s, 1H); 13C NMR (125 MHz, CDCl3)
d 20.8, 23.6, 119.7, 122.7, 123.6, 126.6, 126.7, 127.3, 128.6, 128.8,
133.4, 136.6, 137.8, 145.0, 146.5, 159.1, 161.8. Anal. Calc. for
C29H27BN4O: C, 75.99; H, 5.94; N, 12.22. Found: C, 76.07; H, 6.06;
N, 12.18%.
4-Methyl-2-(4-methylphenyl)-3,3,5-triphenyl-4H-1,2,4,3k4-triazab-
orine-6-carboxanilide (4c). Recrystallization from toluene, orange
crystals (1.24 g, 23%): m.p. 225–229 °C; 1H NMR (500 MHz, CDCl3)
d 2.26 (s, 3H), 2.80 (s, 3H), 6.94–6.97 (m, 3H), 7.14–7.24 (m, 12H),
7.35–7.36 (m, 4H), 7.40–7.45 (m, 5H), 8.93 (s, 1H); 13C NMR
(125 MHz, CDCl3) d 20.9, 40.4, 119.4, 123.2, 123.6, 126.3, 126.6,
127.4, 128.4, 128.6, 128.9, 129.3, 133.8, 134.0, 136.4, 138.0,
144.8, 145.4, 159.1, 160.6. Anal. Calc. for C35H31BN4O: C, 78.65;
H, 5.85; N, 10.48. Found: C, 78.63; H, 6.05; N, 10.47%.
4.2. Rearrangement of oxazaborines
The appropriate oxazaborines (3 mmol) was dissolved in DMF
(8 mL) and the solution was refluxed (the reaction times and
resulting yields are shown in Table 3). DMF was evaporated in va-
cuo and the residue was subjected to the column chromatography
over silica gel (dichloromethane).
Method B. The procedure was the same as for the method A,
excepting re-melted and finally grounded sodium acetate (2.46 g,
30 mmol) was added to a stirred solution of b-enaminoamide
and 4-methylbenzenediazonium tetraphenylborate. The following
compounds were prepared by the procedure described.
Compound 2a. Yellow crystals; 3.54 g (68%).
4.2.1. 2,2,3,6-Tetraphenyl-1-methyl-5-[(4-methylphenyl)hydrazono]-
1H-1,3,2k4-diazaborine-4-one (3c)
Recrystallization from cyclohexane-toluene, yellow crystals:
m.p. 232–235 °C; 1H NMR (500 MHz, CDCl3) d 2.21 (s, 3H), 2.80
(s, 3H), 6.55–6.56 (m, 2H), 6.70–6.72 (m, 2H), 6.95–6.96 (m, 2H),
6.98–7.00 (m, 3H), 7.20–7.26 (m, 8H), 7.48–7.50 (m, 7H), 15.27
(s, 1H); 13C NMR (125 MHz, CDCl3) d 20.7, 41.0, 115.3, 124.3,
125.6, 127.0, 127.1, 127.9, 128.3, 128.5, 129.3, 129.8, 132.9,
133.9, 134.6, 139.4, 141.0, 145.9, 163.1, 171.8. Anal. Calc. for
C35H31BN4O: C, 78.65; H, 5.85; N, 10.48. Found: C, 78.91; H, 6.13;
N, 10.49%.
Compound 2b. Yellow crystals; 2 g (44%).
Compound 2c. Yellow crystals; 0.23 g (4%).
Compound 2d. Yellow crystals; 0.6 g (13%).
Compound 4a. Yellow crystals; 0.17 g (3%).
3-Methylamino-2-(4-methylphenyldiazenyl)-N,3-diphenylprop-2-
enamide (5c). The title compound was obtained chromatographi-
cally as yellow crystals from the same reaction mixture as the
compound 2c (1.13 g, 31%): recrystallization from ethanol, m.p.
123.5–127 °C; 1H NMR (500 MHz, CDCl3) d 2.15 (s, 0.87H, min.),
2.22 (s, 3H, maj.), 2.81 (d, 3H, 3J = 5.2 Hz, maj.), 3.12 (s, 0.83H,
min.), 6.61–6.66 (m, 0.52H, min.), 6.88–6.90 (m, 0.69H, min.),
4.2.2. 1,6-Dimethyl-5-[(4-methylphenyl)hydrazono]-2,2,3-triphenyl-
1H-1,3,2k4-diazaborine-4-one (3d)
Recrystallization from ethanol, yellow crystals: m.p. 205.5–
208 °C; 1H NMR (500 MHz, CDCl3) d 2.30 (s, 3H), 2.56 (s, 3H),
3.00 (s, 3H), 6.48–6.50 (m, 2H), 6.95–6.96 (m, 3H), 7.12–7.14 (m,